Ferguson Wellman Capital Management’s Novo Nordisk NVO Stock Holding History

Ferguson Wellman Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$227K	Buy	+4,727	New	+$203K	﹤0.01%	414
2021 Q1	–	Sell	-189,720	Closed	-$6.63M	–	376
2020 Q4	$6.63M	Sell	189,720 -184,200	-49%	-$6.37M	0.16%	118
2020 Q3	$13M	Buy	373,920 +2,960	+0.8%	+$98.7K	0.36%	74
2020 Q2	$12.1M	Buy	370,960 +7,986	+2%	+$255K	0.37%	69
2020 Q1	$10.9M	Buy	362,974 +6,600	+2%	+$197K	0.41%	65
2019 Q4	$10.3M	Sell	356,374 -7,886	-2%	-$218K	0.3%	87
2019 Q3	$9.42M	Buy	364,260 +13,328	+4%	+$337K	0.3%	90
2019 Q2	$8.96M	Buy	350,932 +158	+0%	+$3.9K	0.3%	91
2019 Q1	$9.17M	Buy	350,774 +14,000	+4%	+$344K	0.31%	87
2018 Q4	$7.76M	Buy	336,774 +13,740	+4%	+$305K	0.3%	88
2018 Q3	$7.61M	Buy	+323,034	New	+$7.88M	0.25%	98

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Ferguson Wellman Capital Management's NVO Position: Q2 2026 in Review

Ferguson Wellman Capital Management opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,727 shares worth $227K. The stake represents ﹤0.01% of the portfolio and ranks #414 among its holdings. This is a return to the name: Ferguson Wellman Capital Management previously reported a position in NVO as recently as Q4 2020.

Ferguson Wellman Capital Management first reported a position in NVO in Q3 2018 and has held it in 11 quarters since. The position peaked at $13M in Q3 2020. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Ferguson Wellman Capital Management held 4,727 shares of Novo Nordisk worth $227K as of Q2 2026.
Novo Nordisk was a new Ferguson Wellman Capital Management position in Q2 2026.
Novo Nordisk made up ﹤0.01% of Ferguson Wellman Capital Management's portfolio in Q2 2026, its #414 holding.
Ferguson Wellman Capital Management first reported a position in Novo Nordisk in Q3 2018 and has held it in 11 quarters since.
Ferguson Wellman Capital Management's Novo Nordisk position peaked at $13M in Q3 2020.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Ferguson Wellman Capital Management's 13F filing for Q2 2026, filed 23 Jul 2026.